Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2008-01-15
2008-01-15
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S424000, C564S428000
Reexamination Certificate
active
07319171
ABSTRACT:
The present invention is directed to Form II of sertraline hydrochloride and novel methods for its preparation. According to the present invention, sertraline hydrochloride Form II may be produced directly form sertraline base or sertraline mandelate. It may also be produced from sertraline hydrochloride solvate and hydrate forms, and crystallized from new solvent systems. Pharmaceutical compositions containing sertraline hydrochloride Form II and methods of treatment using such pharmaceutical compositions are also disclosed.
REFERENCES:
patent: 4536518 (1985-08-01), Welch, Jr. et al.
patent: 5082970 (1992-01-01), Braish
patent: 5248699 (1993-09-01), Sysko et al.
patent: 5463126 (1995-10-01), Williams
patent: 5734083 (1998-03-01), Wilson et al.
patent: 6452054 (2002-09-01), Aronhime et al.
patent: 6495721 (2002-12-01), Schwartz et al.
patent: 6897340 (2005-05-01), Borochovitch et al.
patent: 2004/0030190 (2004-02-01), Borochovitch et al.
patent: 2004/0220279 (2004-11-01), Schwartz et al.
patent: 765/MAS/00 (2000-09-01), None
patent: 2000-26378 (2000-01-01), None
patent: 2000-26379 (2000-01-01), None
patent: 99/47486 (1999-09-01), None
patent: WO 01/32601 (2001-05-01), None
patent: WO 01/90049 (2001-11-01), None
patent: WO 02/096859 (2002-12-01), None
Willard M. Welch et al. “Nontricyclic Antidepressant Agents Derived from cis- and trans-1-Amino-4-aryltetralins”, 1984, Journal of Medicinal Chemistry, vol. 27, No. 11, pp. 1508-1515.
G.M. Wall, “Pharmaceutical Applications of Drug Crystal Studies,” Pharmaceutical Manufacturing, vol. 3, No. 2, Feb. 1986, pp. 33-42.
J.K. Haleblian et al., “Pharmaceutical Applications of Polymorphism,” Journal of Pharmaceutical Sciences, vol. 58, No. 8, Aug. 1969, pp. 911-929.
J.K. Haleblian, “Characterization of Habits and Crystalline Modification of Solids and Their Pharmaceutical Applications,” Journal of Pharmaceutical Sciences, vol. 64, No. 8, Aug. 1975, pp. 1269-1288.
Protest Under 37 C.F.R. §1.291(a); U.S. Appl. No. 10/111,947, filed Apr. 26, 2002, Polymorphic Forms of Sertraline Hydrochloride; Protest filed Oct. 20, 2003.
Declaration of Professor Gautam R. Desiraju, Ph.D., in Support of Opposition to the Grant of Indian Application for Patent No. 192,257 filed Sep. 15, 2000; Declaration filed Oct. 19, 2004.
Notice of Opposition to Grant of a Patent, against Indian Application for Patent No. 192,257 filed Sep. 15, 2000, Notice filed Aug. 25, 2004.
Written Statement of Opposition to Grant of a Patent against Indian Application for Patent No. 192,257 filed Sep. 15, 2000; Statement filed Oct. 23, 2004.
Aronhime Judith
Liberman Anita
Mendelovici Marioara
Nidam Tamar
Schwartz Eduard
Davis Brian
Kenyon & Kenyon LLP
Teva Pharmaceutical Industries Ltd.
LandOfFree
Sertraline hydrochloride form II and methods for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sertraline hydrochloride form II and methods for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sertraline hydrochloride form II and methods for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2809247